DUBLIN--(BUSINESS WIRE)--Dec 6, 2018--The "Market for Active Pharmaceutical Ingredients in Japan - Forecast and Analysis 2018" report has been added to ResearchAndMarkets.com's offering.

Japan is one of the biggest pharmaceutical markets in the world, and the industry is expected to keep growing at a moderate pace in the coming years. As the Japanese population grows older in comparison to other markets, the government has been responding to its aging population by easing several regulations and also introducing innovative new drugs into the market.

It is expected that the pharmaceutical market in Japan, worth just under USD 70 billion at the end of 2016, will cross USD 73 billion by 2021.

In 2017, the Japanese market for active pharmaceutical ingredients (APIs) was one of the biggest in terms of revenues and had a share of nearly 55% of the global API industry.

However, due to severe fluctuations in the Japanese currency against the US dollar as well as the high level of maturity evident in the Japanese pharmaceutical sector, it is expected that the market will grow at a slower than usual rate in the coming years.

Companies Profiled

Allergan PLCAurobindo PharmaBASF SEBoehringer Ingelheim GmbHBristol-Myers Squibb CompanyCipla Ltd.Daiichi Sankyo Company LimitedDr. Reddy's Laboratories LimitedLupin LimitedMedtronic PLCMylan Inc.Novartis AGPfizer Inc.Ranbaxy LaboratoriesSun Pharmaceutical Industries LimitedTeva Pharmaceutical Industries Limited

Key Topics Covered

A. Executive Summary

B. Introduction to Active Pharmaceutical Ingredients

C. Global Market for Active Pharmaceutical Ingredients (APIs)

D. Market for Active Pharmaceutical Ingredients (APIs) in Asia Pacific

E. Market for Active Pharmaceutical Ingredients (APIs) in Japan

F. API Market in Japan: Industry Segmentation

G. Major Industry Players

H. Glossary of Terms

I. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/jcpcnm/2018—market—for?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181206005314/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Pharmaceutical Intermediates



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/06/2018 05:07 AM/DISC: 12/06/2018 05:07 AM


Copyright Business Wire 2018.


(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.